MFS
Mirabella Financial Services Portfolio holdings
AUM
$953M
This Quarter Return
-3.14%
1 Year Return
+26.75%
3 Year Return
+90.29%
5 Year Return
+169.53%
10 Year Return
–
AUM
$879M
AUM Growth
+$879M
(-10%)
Cap. Flow
-$69.3M
Cap. Flow
% of AUM
-7.89%
Top 10 Holdings %
Top 10 Hldgs %
42.47%
Holding
741
New
352
Increased
66
Reduced
89
Closed
224
Top Buys
| 1 |
iShares Expanded Tech-Software Sector ETF
IGV
|
$27.2M |
| 2 |
Invesco QQQ Trust
QQQ
|
$24.2M |
| 3 |
Linde
LIN
|
$21.5M |
| 4 |
3M
MMM
|
$11.8M |
| 5 |
iShares US Medical Devices ETF
IHI
|
$11.3M |
Top Sells
| 1 |
iShares MSCI United Kingdom ETF
EWU
|
$23.5M |
| 2 |
Global X FinTech ETF
FINX
|
$14.1M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
$12M |
| 4 |
Charles River Laboratories
CRL
|
$11.5M |
| 5 |
Teleflex
TFX
|
$11M |
Sector Composition
| 1 | Healthcare | 10.76% |
| 2 | Financials | 10.12% |
| 3 | Technology | 9.05% |
| 4 | Industrials | 7.87% |
| 5 | Materials | 4.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
DocGo
DCGO
$152M
| $121K | 0.01% |
13,119
-6,630
| -34% | -$61.2K |
|
427
Entravision Communication
EVC
$226M
| $121K | 0.01% |
+18,800
| New | +$121K |
|
428
Rhythm Pharmaceuticals
RYTM
$6.78B
| $121K | 0.01% |
+10,530
| New | +$121K |
|
|
PFSW
429
DELISTED
PFSweb, Inc.
PFSW
| $117K | 0.01% |
+10,258
| New | +$117K |
|
430
Perella Weinberg Partners
PWP
$1.31B
| $115K | 0.01% |
+12,213
| New | +$115K |
|
431
Acco Brands
ACCO
$354M
| $111K | 0.01% |
+13,903
| New | +$111K |
|
432
Vaalco Energy
EGY
$397M
| $106K | 0.01% |
+16,200
| New | +$106K |
|
433
NextNav
NN
$2.15B
| $104K | 0.01% |
+13,899
| New | +$104K |
|
|
SYRS
434
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $102K | 0.01% |
+85,900
| New | +$102K |
|
435
Gannett
GCI
$604M
| $92K | 0.01% |
+20,365
| New | +$92K |
|
436
P3 Health Partners
PIII
$27.9M
| $91K | 0.01% |
+11,600
| New | +$91K |
|
437
Aligos Therapeutics
ALGS
$73.3M
| $88K | 0.01% |
+40,900
| New | +$88K |
|
438
Permian Resources
PR
$9.69B
| $88K | 0.01% |
+10,822
| New | +$88K |
|
439
CytomX Therapeutics
CTMX
$343M
| $84K | 0.01% |
+31,400
| New | +$84K |
|
|
EPZM
440
DELISTED
Epizyme, Inc
EPZM
| $83K | 0.01% |
+72,100
| New | +$83K |
|
|
HOOK
441
DELISTED
HOOKIPA Pharma
HOOK
| $82K | 0.01% |
+36,100
| New | +$82K |
|
442
Owlet
OWLT
$126M
| $82K | 0.01% |
18,400
+4,330
| +31% | +$19.3K |
|
443
Cartesian Therapeutics
RNAC
$265M
| $82K | 0.01% |
+67,000
| New | +$82K |
|
|
EQRX
444
DELISTED
EQRx, Inc. Common Stock
EQRX
| $81K | 0.01% |
+19,540
| New | +$81K |
|
445
KORE Group Holdings
KORE
$40.9M
| $80K | 0.01% |
13,308
+3,265
| +33% | +$19.6K |
|
|
APEN
446
DELISTED
Apollo Endosurgery, Inc.
APEN
| $80K | 0.01% |
+13,151
| New | +$80K |
|
447
FTC Solar
FTCI
$94.5M
| $79K | 0.01% |
+16,080
| New | +$79K |
|
448
Solid Biosciences
SLDB
$441M
| $78K | 0.01% |
+65,100
| New | +$78K |
|
|
SHCR
449
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $78K | 0.01% |
31,580
-4,070
| -11% | -$10.1K |
|
450
Genworth Financial
GNW
$3.49B
| $77K | 0.01% |
+20,319
| New | +$77K |
|